Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine sacral canal block effective concentration in neonatal perianal abscess surgery
ChiCTR2200057870Phase 4Completed
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lidocaine in perianal abscess, sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: MEC50 (50% minimum effective concentration of lidocaine), MEC90 (90% minimum effective concentration of lidocaine) and 1 more. Started Apr 2022; status: completed.
02
Drugs
lidocaine
03
Conditions
perianal abscess
Beyond the preview
Go deeper on ChiCTR2200057870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057870.